Patent Assignment
Reel/Frame 015356/0184
Change of Name
Recorded: 2004-05-24
Received: 2004-05-26
Pages: 21
Assignor
RIBOZYME PHARMACEUTICALS, INC.
Executed: 2003-04-16
Assignee
SIRNA THERAPEUTICS, INC.
2950 WILDERNESS PLACE, BOULDER, CO, 80301, UNITED STATES
Covered Properties
(2)
RNA interference mediated inhibition of protein typrosine phosphatase-1B (PTP-1B) gene expression using short interfering RNA
Application:
10/206,705 →
Network Reverse Auction and Spending Analysis Methods
Application:
09/781,937 →